U.K. Health Authority Investigates Epilepsy Drug’s Link to Autism
August 30, 2022
(The Scientist) – The U.K. Medicines and Healthcare products Regulatory Agency (MHRA) is investigating the safety of prenatal exposure to an anti-seizure drug called topiramate after a study published in May showed that it roughly triples a child’s likelihood of having autism or intellectual disability. Another anti-seizure drug, called valproate, is already known to contribute to autism; in 2018, the European Medicines Agency partially banned the use of valproate during pregnancy. It also recommends against taking topiramate to manage migraines during pregnancy, but it does not advise getting off the medication during pregnancy if using it to manage seizures. (Read More)